Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:dateCreated
1992-12-22
pubmed:abstractText
Over 95% of the pyridoxal phosphate (PLP) in skeletal is bound to one protein, glycogen phosphorylase. This, and the fact that phosphorylase constitutes approx. 5% of the soluble protein in skeletal muscle, introduce the possibility that PLP might be used as a specific label to identify degradation intermediates of the enzyme. In this investigation, we have developed immunological methods, using a monoclonal antibody to PLP and polyclonal antibodies to phosphorylase, to detect degradation intermediates in vitro and in vivo. We have identified a family of degradation intermediates of glycogen phosphorylase in the high-speed-supernatant fraction of mouse skeletal muscle. These peptides react with both types of antibodies and are in the size and concentration range expected for degradation intermediates in a model in which the committed step is followed by rapid clearance of the products. Changes in amounts of degradation intermediates are examined in physiological or pathological conditions in which the rate of degradation of phosphorylase is altered.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/1445274-1417751, http://linkedlifedata.com/resource/pubmed/commentcorrection/1445274-1883323, http://linkedlifedata.com/resource/pubmed/commentcorrection/1445274-2001360, http://linkedlifedata.com/resource/pubmed/commentcorrection/1445274-2187867, http://linkedlifedata.com/resource/pubmed/commentcorrection/1445274-2264827, http://linkedlifedata.com/resource/pubmed/commentcorrection/1445274-2591639, http://linkedlifedata.com/resource/pubmed/commentcorrection/1445274-2943737, http://linkedlifedata.com/resource/pubmed/commentcorrection/1445274-3046602, http://linkedlifedata.com/resource/pubmed/commentcorrection/1445274-3311194, http://linkedlifedata.com/resource/pubmed/commentcorrection/1445274-388439, http://linkedlifedata.com/resource/pubmed/commentcorrection/1445274-3898080, http://linkedlifedata.com/resource/pubmed/commentcorrection/1445274-3912229, http://linkedlifedata.com/resource/pubmed/commentcorrection/1445274-4018379, http://linkedlifedata.com/resource/pubmed/commentcorrection/1445274-4063401, http://linkedlifedata.com/resource/pubmed/commentcorrection/1445274-4760132, http://linkedlifedata.com/resource/pubmed/commentcorrection/1445274-4799824, http://linkedlifedata.com/resource/pubmed/commentcorrection/1445274-513128, http://linkedlifedata.com/resource/pubmed/commentcorrection/1445274-564621, http://linkedlifedata.com/resource/pubmed/commentcorrection/1445274-6413266, http://linkedlifedata.com/resource/pubmed/commentcorrection/1445274-6822543, http://linkedlifedata.com/resource/pubmed/commentcorrection/1445274-6822578, http://linkedlifedata.com/resource/pubmed/commentcorrection/1445274-6996565, http://linkedlifedata.com/resource/pubmed/commentcorrection/1445274-7009252, http://linkedlifedata.com/resource/pubmed/commentcorrection/1445274-736888
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
0264-6021
pubmed:author
pubmed:issnType
Print
pubmed:day
15
pubmed:volume
288 ( Pt 1)
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
291-6
pubmed:dateRevised
2010-9-7
pubmed:meshHeading
pubmed:year
1992
pubmed:articleTitle
Immunological detection of degradation intermediates of skeletal-muscle glycogen phosphorylase in vitro and in vivo.
pubmed:affiliation
Department of Biochemistry, University of Liverpool, U.K.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't